News & Cases

December 18, 2018

Cost-effectiveness PCT guided therapy in reduction AB resistance

Antibiotic (AB) resistance and Clostridium difficile infections (CDI) have become an increasing problem when AB is overused or wrongfully prescribed. […]
August 29, 2018

‘Future of care – care of the future’ by Bert Vrijhoef

Thinking about care of the future, self-care is increasingly becoming important. At the Self-Care Summit in Copenhagen from 11-12 April 2018, I […]
July 27, 2018

What have we been up to at Panaxea?

Looking back at the first half year of 2018… Almost 7  months have already flown by of the new year […]
February 14, 2018

The challenge of joint decision making with vulnerable people

On January 26th, the congress ‘Joint decision-making with vulnerable people: a challenge’ was held in Utrecht. During this congress, the […]
February 13, 2018

Persoonsgerichte zorg in de (eerstelijns) zorgpraktijk

Wat is er nodig voor het effectief toepassen van persoonsgerichte zorg in de (eerstelijns) zorgpraktijk? En hoe doen we dat […]
November 24, 2017

Building digital healthcare together

During the 20th edition of the Electronic Commerce Platform (ECP) Annual Congress on November 16th, the building blocks of the […]
July 18, 2017

Presentation of the Joint European Horizon Scanning System on HTAi conference

During the latest HTAi conference in Rome, themed “Towards an HTA Ecosystem: From Local Needs to Global Opportunities”, CEO Isabelle […]
July 11, 2017

Dure geneesmiddelen: een probleem voor de volksgezondheid in Nederland?

Door een toename van diagnose en behandelmogelijkheden neemt de incidentie en prevalentie van zeldzame aandoeningen snel toe. Onder andere als […]
June 20, 2017

Big Data in healthcare: more clear, less fear?

On May 18th 2017 the Dutch Ministry of Health, Welfare and Sports in cooperation with the Academic Medical Centre Amsterdam […]
May 23, 2017

The scaling up of integrated care: the importance of context

During the 17th International Conference on Integrated Care (ICIC), held in Dublin last week, people from different countries presented strategies […]
April 7, 2017

Panaxea hosts MedtechMeeting in Amsterdam

On 23rd of march 2017 Panaxea hosted the MedtechMeeting at the ‘Silicon Valley’ of Amsterdam: Science Park. This event was […]
February 22, 2017

Panaxea’s Janne Mewes about the importance of aftercare in cancer patients for employers

As the incidence of cancer is rising and more patients survive their disease, the number of people within the population […]
February 22, 2017

The economics of bringing precision medicine to the clinic

Precision Medicine’s value is undeniable. But what about its financial impact? And how should we assess its value? Read the […]
February 6, 2017

Digital health innovations: assessment of their impact on health and economic outcomes

With the ageing population in Europe, an increase in the number of people with chronic diseases, limited health care budgets […]
February 1, 2017

Thermo Fisher Scientific: safely reduce antibiotic exposure

Antibiotics are a limited resource. At the current pace of injudicious use, all antibiotics will soon become ineffective. Panaxea together […]
October 4, 2016

Integrated care: unlocking the mysteries

Mystery is not a word that we often connect with health and care as these are worlds in which we […]
August 25, 2016

The broader view of health economics

Thermo Fisher is a long time client of Panaxea. This resulted among others in a tailor made health economic model […]
August 23, 2016

The challenges and opportunities of articulating the value of your diagnostics

We added a new white paper about the challenges and opportunities of articulating the value of your diagnostics! Please click […]
August 17, 2016

Panaxea joins Flanders Innovation & Entrepreneurship

We’re proud to announce that Panaxea is now a certified service provider for the Flemish government under the SME grants […]
June 20, 2016

MAFEIP follow up: Panaxea joins European Innovation Partnership on Active and Healthy Ageing Action Groups

Following an earlier involvement with the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA), Panaxea is now a […]
June 20, 2016

Further research for predictive biomarkers

Lotte Steuten worked along with Anna Miquel-Cases, Valesca Retèl, and Wim van Harten on a paper on decision about design […]
June 13, 2016

New VOKA white paper: Value based care innovation and logistics

Panaxea contributed to the new Voka white paper: Value based care innovation and logistics. This white paper shares the vision of […]
June 6, 2016

From re-search to pro-search: P-value

Innovations in healthcare transform the way healthcare gets delivered and the lives of people. Healthcare is getting person-centred and people […]
June 1, 2016

Organizational innovations to accelerate technology transfer and translational research — Do they work?

Recently, a paper by Lotte Steuten was published in ‘OMICS: A Journal of Integrative Biology’. This paper is a result […]
May 30, 2016

Senior Consultant Vacancy

Panaxea is seeking to find an experienced and passionate senior consultant with an interest in business development to expand our […]
May 26, 2016

Bert Vrijhoef at Our Future Health

Our Future Health started today with presentations from the Dutch Minister of Health, Welfare and Sport Edith Schippers, and Ex-European […]
April 12, 2016

Bert Vrijhoef introduced as speaker at Our Future Health

Our Chief Innovation Officer Bert Vrijhoef is introduced today as a speaker at Our Future Health 2016. The event will […]
April 11, 2016

Results from our Customer Satisfaction Survey

As we understand the critical importance of value-assessments to our customers’ innovations, we regularly ask our customers how they value […]
March 31, 2016

Gimon de Graaf and Lotte Steuten co-authors on web-based tool paper

Gimon De Graaf and Lotte Steuten are co-authors on paper about the development of a web-based tool for the assessment […]
March 16, 2016

Interview in ICT & Health with Bert Vrijhoef

Bert Vrijhoef shares his views on the implementation of ICT in health care at an individual, local and global level. […]
March 7, 2016

Introducing Bert Vrijhoef as our new CIO!

As of March 2015, we are delighted to welcome Prof. dr. Bert Vrijhoef as the Chief Innovation Officer (CIO) of […]
February 17, 2016

Three take home messages from the Economic Evaluation presentation

The new Dutch economic evaluation guideline was presented yesterday. Panaxea attended this meeting to be aware of this new guideline, […]
February 10, 2016

The new Dutch economic evaluation guideline

All parties in health care, from governments to hospitals, are bound to budgets. The use of economic evaluations helps these […]
February 2, 2016

Panaxea takes place in CRADL consortium

Panaxea is proud to announce that it takes place in this consortium with 11 other parties, like the Middlesex University […]
November 9, 2015

Panaxea posters, presentations and workshops @ISPOR Milan 9-11 November 2015

Dear ISPORIAN, Panaxea (www.panaxea.eu) provides customized, high-quality analyses about the added value of products and interventions in the care pathway. […]
June 3, 2015

Articulating the value of diagnostics

Diagnostics face difficulties in current market conditions to obtain reimbursement and to enter the market efficiently. This white paper highlights […]
May 19, 2015

Health economic evaluation of a strict glucose control guideline implemented using point-of-care testing in three Intensive Care Units in the Netherlands

Health economic evaluation of a strict glucose control guideline implemented using point-of-care testing in three Intensive Care Units in the […]
May 19, 2015

Generic decision model for diagnostic tests

To give (potential) clients a preliminary insight in the cost-effectiveness of their diagnostic test, we developed an online generic decision […]
May 19, 2015

Marloes van der Maas joined board “Jong NVTAG”

Jong NVTAG is a Dutch organization that aims to address the need of young professionals in the field of health […]
April 20, 2015

Long-term cost–effectiveness of Oncotype DX® versus current clinical practice from a Dutch cost perspective

Michelle Kip, Helma Monteban & Lotte Steuten, Long-term cost–effectiveness of Oncotype DX® versus current clinical practice from a Dutch cost […]
March 31, 2015

Courses

Building upon our expertise and experience, Panaxea can organize or contribute to courses, seminars and workshops on a wide range […]
March 31, 2015

Introduction course to early Health Technology Assessment by Panaxea

Panaxea has cooperated with the University of Twente department Health Technology and Services Research in developing a one-day introductory course […]
March 5, 2015

Maarten IJzerman nominated President-elect ISPOR

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a member-driven organization led by a diverse Board of Directors […]
February 25, 2015

Systematic literature review

For a medical device company developing blood glucose meters, we performed a systematic literature review on self-monitoring of blood glucose […]
February 25, 2015

Market access and reimbursement report

A medical device company has developed a new technology that could improve the visualization and treatment of the affected heart […]
February 25, 2015

Cost-effectiveness and budget impact model for a diagnostic test

Allergic Rhinitis (AR) is a condition where an inflammatory reaction of the immune system is caused by specific allergens. Respiratory […]
September 7, 2014

Panaxea at ISPOR Amsterdam, 10-13 November 2014

Panaxea will be one of the exhibiting organizations at the 17th Annual ISPOR European Congress in Amsterdam (RAI). Visit our booth #913 […]
September 2, 2014

New office

Our office has been relocated to a new address! Hengelosestraat 221 7521 AC Enschede The Netherlands  [su_gmap address=”Hengelosestraat 221″]
January 22, 2014

Health economic modeling

For a global health company we evaluated the expected incremental cost-effectiveness of one of their products. The cost-effectiveness outcome was […]
January 22, 2014

Time-and-motion study

For a large pharmaceutical company Panaxea was asked to perform a time-and-motion study to compare two administration methods of a […]
January 22, 2014

Impact-analysis public-private partnership (PPP)

In this project we performed an impact-analysis on scientific, translational/clinical and socio-economic aspects of a public-private partnership (PPP). This PPP […]
January 22, 2014

Health economic analysis of a POCT assay

Point of Care Testing (POCT) is generally perceived to be more expensive on a unit-cost base than testing performed in […]
January 22, 2014

Decision analytic support model to guide implementation of laboratory assay

Our client noticed that the uptake of one of their laboratory assays used to detect a bacterial infection, was lagging […]
January 22, 2014

Value dossier and health economic model for a provider of haemodialysis

A large provider of haemodialysis services wanted to increase the market share of one of their products. They requested Panaxea […]